Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit)

v3.22.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance as of beginning of period (in shares) at Dec. 31, 2020 117,734,383        
Balance as of beginning of period at Dec. 31, 2020 $ 123,704,000        
Balance as of end of period (in shares) at Jun. 30, 2021 117,734,383        
Balance as of end of period at Jun. 30, 2021 $ 123,704,000        
Balance as of beginning of period (in shares) at Dec. 31, 2020   16,003,558      
Balance as of beginning of period at Dec. 31, 2020 $ (107,821,000) $ 1,000 $ 14,954,000 $ 0 $ (122,776,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 165,000 165,020      
Stock Issued During Period, Value, Stock Options Exercised $ 283,000   283,000    
Adjustments to Additional Paid in Capital, Warrant Issued 134,000   134,000    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 1,075,000   1,075,000    
Net income (loss) (26,086,000)       (26,086,000)
Balance as of end of period (in shares) at Jun. 30, 2021   16,168,578      
Balance as of end of period at Jun. 30, 2021 $ (132,415,000) $ 1,000 16,446,000 0 (148,862,000)
Balance as of beginning of period (in shares) at Mar. 31, 2021 117,734,383        
Balance as of beginning of period at Mar. 31, 2021 $ 123,704,000        
Balance as of end of period (in shares) at Jun. 30, 2021 117,734,383        
Balance as of end of period at Jun. 30, 2021 $ 123,704,000        
Balance as of beginning of period (in shares) at Mar. 31, 2021   16,042,945      
Balance as of beginning of period at Mar. 31, 2021 (120,947,000) $ 1,000 15,376,000 0 (136,324,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   125,633      
Stock Issued During Period, Value, Stock Options Exercised 244,000   244,000    
Adjustments to Additional Paid in Capital, Warrant Issued 66,000   66,000    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 760,000   760,000    
Net income (loss) (12,538,000)       (12,538,000)
Balance as of end of period (in shares) at Jun. 30, 2021   16,168,578      
Balance as of end of period at Jun. 30, 2021 $ (132,415,000) $ 1,000 16,446,000 0 (148,862,000)
Balance as of beginning of period (in shares) at Dec. 31, 2021 0        
Balance as of beginning of period at Dec. 31, 2021 $ 0        
Balance as of end of period (in shares) at Jun. 30, 2022 0        
Balance as of end of period at Jun. 30, 2022 $ 0        
Balance as of beginning of period (in shares) at Dec. 31, 2021   183,232,494      
Balance as of beginning of period at Dec. 31, 2021 $ 110,415,000 $ 2,000 340,294,000 (14,000) (229,867,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,547,000        
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   1,546,631      
Issuance of common stock upon exercise of stock options and release of restricted stock units $ 570,000   570,000    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 9,933,000 $ 130,483 9,933,000    
Net income (loss) 62,608,000       62,608,000
Other comprehensive loss (943,000)     (943,000)  
Balance as of end of period (in shares) at Jun. 30, 2022   184,909,608      
Balance as of end of period at Jun. 30, 2022 $ 182,583,000 $ 2,000 350,797,000 (957,000) (167,259,000)
Balance as of beginning of period (in shares) at Mar. 31, 2022 0        
Balance as of beginning of period at Mar. 31, 2022 $ 0        
Balance as of end of period (in shares) at Jun. 30, 2022 0        
Balance as of end of period at Jun. 30, 2022 $ 0        
Balance as of beginning of period (in shares) at Mar. 31, 2022   183,557,946      
Balance as of beginning of period at Mar. 31, 2022 49,603,000 $ 2,000 345,418,000 (608,000) (295,209,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)   1,221,179      
Issuance of common stock upon exercise of stock options and release of restricted stock units 403,000   403,000    
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 4,976,000 $ 130,483 4,976,000    
Net income (loss) 127,950,000       127,950,000
Other comprehensive loss (349,000)     (349,000)  
Balance as of end of period (in shares) at Jun. 30, 2022   184,909,608      
Balance as of end of period at Jun. 30, 2022 $ 182,583,000 $ 2,000 $ 350,797,000 $ (957,000) $ (167,259,000)